Average Co-Inventor Count = 7.69
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (21 from 125 patents)
2. Valo Early Discovery, Inc. (7 from 15 patents)
3. Valo Health, Inc. (6 from 29 patents)
4. Astrazeneca Ab (5 from 1,500 patents)
39 patents:
1. 12162888 - Carboxamides as ubiquitin-specific protease inhibitors
2. 12043623 - Purinones as ubiquitin-specific protease 1 inhibitors
3. 12018030 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
4. 11795171 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
5. 11739071 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
6. 11524966 - Carboxamides as ubiquitin-specific protease inhibitors
7. 11325917 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
8. 11247987 - Inhibiting ubiquitin specific peptidase 30
9. 11161848 - Purinones as ubiquitin-specific protease 1 inhibitors
10. 10981915 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
11. 10934299 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
12. 10927130 - Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
13. 10913753 - Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
14. 10906916 - Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
15. 10889592 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors